Product Information
NALOXONE 2 MG/2 ML SYRINGE is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $12.7410 per ML under NDC 00641620510. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Jun 10, 2022. Its Orange Book therapeutic-equivalence code is AP.
Strength
1 mg/mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00641620510
Classification
Generic
Dosage Form
INJECTION
Route
INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
NALOXONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212300FDA Approved
6/10/2022
TE Code
AP
On Market Since
6/10/2022
Pharmacological Classes
Price Statistics
The NADAC for NALOXONE 2 MG/2 ML SYRINGE has been published 129 times since Apr 17, 2024, and over the history we have for it it has risen 23.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.7410 per ML |
|---|---|
| All-time high | $13.9470 (Aug 12, 2026) |
| All-time low | $10.3168 (Apr 17, 2024) |
| 52-week high | $13.9470 |
| 52-week low | $11.2939 |
| Median price | $11.7100 |
| Average price | $11.9810 |
| Largest weekly change | +8.1% (Mar 18, 2026) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Naloxone Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NALOXONE 2 MG/2 ML SYRINGE?
The current National Average Drug Acquisition Cost (NADAC) for NALOXONE 2 MG/2 ML SYRINGE, manufactured by Hikma Pharmaceuticals USA Inc., is $12.7410 per ML (NDC 00641620510), effective Sep 30, 2026.
How has the price of NALOXONE 2 MG/2 ML SYRINGE changed over time?
Over the history we have for it, the NADAC for NALOXONE 2 MG/2 ML SYRINGE has risen 23.5%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for NALOXONE 2 MG/2 ML SYRINGE?
Since Apr 17, 2024, the NADAC for NALOXONE 2 MG/2 ML SYRINGE has ranged from a low of $10.3168 (Apr 17, 2024) to a high of $13.9470 (Aug 12, 2026), with a median of $11.7100 per ML.
Are there cheaper alternatives to NALOXONE 2 MG/2 ML SYRINGE?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as NALOXONE 2 MG/2 ML SYRINGE in a comparable dosage form, but none are currently priced below it.
Who manufactures NALOXONE 2 MG/2 ML SYRINGE?
NALOXONE 2 MG/2 ML SYRINGE (NDC 00641620510) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.